All PlansCoverageMedium impact
Renal Denervation for Uncontrolled Hypertension
Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Nephrology, Internal Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
New coverage policy establishes medical necessity criteria for renal denervation procedures (both radiofrequency and ultrasound) for patients with uncontrolled hypertension above 130/80 mmHg despite 3+ antihypertensive medications. Only two FDA-approved devices are covered: Paradise Ultrasound System and Symplicity Spyral System.
Action Required
Immediately: Update prior authorization processes to verify patients meet strict criteria (BP >130/80 mmHg despite 3+ medications from different classes at max doses or medication intolerance, plus failed lifestyle modifications). Verify procedures use only FDA-approved devices (Paradise Ultrasound or Symplicity Spyral systems). Add documentation requirements for contraindications and ensure procedures are performed at specialized centers with multidisciplinary hypertension teams.